RecruitingNCT06828887

Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD

This recruiting study focuses on depression and currently lists sites or participation links in China.

DepressionOtherFrom 18 Years to 65 Years

In plain English

Key information made simple

This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand whether a medication treatment can better prevent setbacks and support longer-term stability. For people living with Depression, small gains in stability can make a meaningful difference over time. If the findings are useful, they could help shape larger studies and better designed support in the future. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including Shanghai Mental Health Center Ethics Committee in Shanghai. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually being able to understand the study and consent and matching the main diagnosis, while common reasons not to take part include active substance or alcohol problems that could affect the results. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT06828887. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in China.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com